북미 활성 의료 이식 장치 시장 – 2028년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

북미 활성 의료 이식 장치 시장 – 2028년까지의 산업 동향 및 예측

  • Medical Devices
  • Published Report
  • Oct 2021
  • North America
  • 350 Pages
  • 테이블 수: 70
  • 그림 수: 38

>북미 활성 의료 이식 장치 시장, 제품별(심장 재동기화 치료 장치(CRT-D), 이식형 심장충격기, 이식형 심장 박동 조절기, 눈 이식, 신경 자극기, 활성 이식형 청각 장치, 심실 보조 장치, 이식형 심장 모니터/삽입형 루프 기록기, 근접 치료, 이식형 포도당 모니터, 드롭드 풋 임플란트, 어깨 임플란트, 이식형 주입 펌프 및 이식형 액세서리), 수술 유형(전통적 수술 방법 및 최소 침습 수술), 시술(신경 혈관, 심혈관, 청력 및 기타), 최종 사용자(병원, 전문 병원, 외래 수술 센터, 병원), 국가(미국, 캐나다, 멕시코) 산업 동향 및 2028년까지의 예측

북미 활성 의료용 이식 장치 시장

시장 분석 및 통찰력: 북미 활성 의료 이식 장치 시장

북미 활성 의료용 이식형 기기 시장은 2021년부터 2028년까지의 예측 기간 동안 상당한 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 7.9%의 CAGR로 성장하고 있으며 2028년까지 12,665.68백만 달러에 도달할 것으로 예상한다고 분석했습니다. 의료 산업의 R&D 활동 증가와 의료 지출 증가는 예측 기간 동안 시장 성장을 촉진하는 주요 원동력입니다. 정부 자금과 투자 증가는 회사가 더 많은 제품을 출시할 수 있는 기회를 제공했습니다. 그러나 이식형 기기의 높은 비용과 제품 리콜은 시장의 주요 과제입니다.

능동적 이식형 의료 기기는 수술 과정을 통해 환자의 신체에 삽입되는 전원 장치로, 수술 후에도 환자 신체에 남아 있도록 설계되었습니다.

기술의 발전이 북미 활성 의료용 이식 장치 시장의 성장을 주도하고 있습니다. 주요 지역에서 신제품 개발 활동에 대한 투자가 증가함에 따라 향후 몇 년 동안 활성 의료용 이식 장치에 대한 수요가 증가할 것으로 예상됩니다. 반면 치료의 비용과 해로운 영향은 시장 성장을 방해하고 있습니다.

북미 활성 의료용 이식형 기기 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 창출, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 당사에 문의하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.

북미 활성 의료용 이식 장치 시장

북미 활성 의료 이식 장치 시장 범위 및 시장 규모

North America Active medical implantable devices market is segmented on the basis of product, surgery type, procedure, and end users. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the North America active medical implantable devices market is segmented into Cardiac Resynchronization Therapy Devices (CRT-D), implantable cardioverter defibrillators, implantable cardiac pacemakers, eye implants, neurostimulators, active implantable hearing devices, ventricular assist devices, implantable heart monitors/ insertable loop recorders, brachytheraphy, implantable glucose monitors, dropped foot implants, shoulder implants, implantable infusion pumps and implantable accessories. In 2021, Cardiac Resynchronization Therapy Devices (CRT-D) segment is expected to dominate the market owing to increase in the demand for implantable devices stoked by their efficient results.
  • On the basis of surgery type the North America active medical implantable devices market is segmented into traditional surgical methods and minimally invasive surgery. In 2021, traditional surgical methods segment is expected to dominate the market as it have reasonable cost and expense of the treatment.
  • On the basis of procedure, the North America active medical implantable devices market is segmented into neurovascular, cardiovascular, hearing and others. In 2021, cardiovascular is expected to dominate the market with the increase in cardiovascular disease.
  • On the basis of end-users, the North America active medical implantable devices market is segmented into hospitals, specialty clinics, ambulatory surgical centers and clinics. In 2021, hospital segment is expected to dominate the market due growing demand of active medical implantable devices

North America Active Medical Implantable Devices Market Country Level Analysis

The North America active medical implantable devices market is analyzed and market size information is provided on the basis of product, surgery type, procedure, end users.

The countries covered in the active medical implantable devices market report are the U.S., Canada, and Mexico.

Active medical implantable devices segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of increasing research development for enhancing the product quality. The U.S is leading the growth of the North America active medical implantable devices market and cardiovascular segment is dominating in this country due to increasing prevalence of diseases in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Increase in advancement and technology for new product development are boosting the market growth of active medical implantable devices growth

North America active medical implantable devices market also provides you with detailed market analysis for every country growth in active medical implantable devices industry with active medical implantable devices drugs sales, impact of advancement in the active medical implantable devices technology and changes in regulatory scenarios with their support for the market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Active Medical Implantable Devices Market Share Analysis

Active medical implantable devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to active medical implantable devices market.

The major companies which are dealing in the North America active medical implantable devices market are NeuroPace, Inc., Axonics, Inc., Stimwave LLC, NEVRO CORP, Second Sight, BIOTRONIK, ABIOMED, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler., Sonova, Zhejiang Nurotron Biotechnology Co., Ltd, Demant A/S, Cochlear Ltd, Microson, Oticon Medical, Nano Retina, GluSense, MED-EL Medical Electronics among others.

Several product launches and agreements are also initiated by the companies worldwide, which are also accelerating the growth of the active medical implantable devices market.

For instance,

  • In March 2021, Medline industries, Inc announced that they have been awarded a prime vendor contract to serve as the exclusive supply vendor for Windsor Lane Health Care, an Ohio-based long-term care facility which has increased its supply chain in United States.
  • 2020년 1월, Medline Industries, Inc.는 Medline Canada 사업에 합류하기 위해 퀘벡 시에 본사를 둔 의료 및 치과용품 유통업체인 Médi-Sélect를 인수한다고 발표했습니다. 이를 통해 유통 및 공급망 네트워크가 확대되었습니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 MARKET APPLICATION COVERAGE GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 INDUSTRY INSIGHTS

5 REGULATORY ANALYSIS

5.1 REGULATION IN EUROPE

5.2 REGULATION IN U.S.

5.3 REGULATION IN CANADA

5.4 REGULATION IN CHINA

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 TECHNOLOGICAL ADVANCEMENT

6.1.2 INCREASING BURDEN OF CARDIOVASCULAR DISEASES, NEUROLOGICAL DISORDERS AND HEARING DISORDERS

6.1.3 INCREASING FDA APPROVAL

6.1.4 RISING AWARENESS FOR MEDICAL IMPLANTS

6.2 RESTRAINTS

6.2.1 HIGH COST OF MEDICAL IMPLANTS

6.2.2 INCREASING RISK OF DEVELOPING INFECTION AND OTHER COMPLICATIONS

6.3 OPPORTUNITIES

6.3.1 INCREASE IN DEMAND FOR MINIMALLY INVASIVE SURGERIES

6.3.2 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS

6.3.3 INCREASE IN THE GERIATRIC POPULATION

6.3.4 RISING HEALTHCARE INFRASTRUCTURE

6.4 CHALLENGES

6.4.1 INCREASING PRODUCT RECALL

6.4.2 SUPPLY CHAIN DISRUPTION DUT TO COVID-19 PANDEMIC OUTBREAK

7 IMPACT OF COVID-19

7.1 IMPACT ON PRICE

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY

7.4 STRATEGIC DECISIONS OF GOVERNMENT AND MANUFACTURERS

7.5 CONCLUSION

8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT

8.1 OVERVIEW

8.2 CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D)

8.3 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.3.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.3.1.1 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.3.1.2 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)/ CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS (CRT-DS)

8.3.1.3 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.3.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS

8.4 IMPLANTABLE CARDIAC PACEMAKERS

8.4.1 DUAL CHAMBER PACEMAKERS

8.4.2 BIVENTRICULAR PACEMAKERS

8.4.3 SINGLE CHAMBER PACEMAKERS

8.5 EYE IMPLANTS

8.6 NEUROSTIMULATORS

8.6.1 SPINAL CORD STIMULATORS

8.6.2 DEEP BRAIN STIMULATORS

8.6.3 BLADDER STIMULATORS

8.6.4 GASTRIC NERVE STIMULATORS

8.6.5 SACRAL NERVE STIMULATORS

8.6.6 LIMB FUNCTION STIMULATORS

8.6.7 VAGUS STIMULATORS

8.6.8 OTHERS

8.7 ACTIVE IMPLANTABLE HEARING DEVICES

8.8 VENTRICULAR ASSIST DEVICES

8.9 IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS

8.1 BRACHYTHERAPY

8.11 IMPLANTABLE GLUCOSE MONITORS

8.12 DROPPED FOOT IMPLANTS

8.13 SHOULDER IMPLANTS

8.14 IMPLANTABLE INFUSION PUMPS

8.15 IMPLANTABLE ACCESSORIES

8.15.1 LEAD

8.15.2 ELECTRODES

8.15.3 ADAPTORS

8.15.4 OTHERS

9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE

9.1 OVERVIEW

9.2 TRADITIONAL SURGICAL METHODS

9.3 MINIMALLY INVASIVE SURGERY

10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE

10.1 OVERVIEW

10.2 CARDIOVASCULAR

10.3 NEUROLOGICAL

10.4 HEARING

10.5 OTHERS

11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER

11.1 OVERVIEW

11.2 HOSPITALS

11.3 AMBULATORY SURGICAL CENTERS

11.4 SPECIALIZED CLINICS

11.5 CLINICS

12 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION

12.1 NORTH AMERICA

12.1.1 U.S.

12.1.2 CANADA

12.1.3 MEXICO

13 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY LANDSCAPE

13.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

14 COMPANY PROFILE

14.1 MEDTRONIC

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENTS

14.2 ABBOTT

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 BOSTON SCIENTIFIC CORPORATION

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 COCHLEAR LTD

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENT

14.5 ABIOMED

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENTS

14.6 AXONICS, INC.

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENTS

14.7 BIOTRONIK SE & CO. KG

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 DEMANT A/S

14.8.1 COMPANY SNAPSHOT

14.8.2 REVENUE ANALYSIS

14.8.3 PRODUCT PORTFOLIO

14.8.4 RECENT DEVELOPMENT

14.9 ECKERT & ZIEGLER.

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT DEVELOPMENTS

14.1 GLUSENSE

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENTS

14.11 MED-EL MEDICAL ELECTRONICS

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT DEVELOPMENTS

14.12 MICROSON

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 NANO RETINA

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 NEUROPACE, INC.

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT DEVELOPMENT

14.15 NEVRO CORP.

14.15.1 COMPANY SNAPSHOT

14.15.2 REVENUE ANALYSIS

14.15.3 PRODUCT PORTFOLIO

14.15.4 RECENT DEVELOPMENTS

14.15.5 RECENT DEVELOPMENTS

14.16 OTICON MEDICAL

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 SECOND SIGHT

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENT

14.18 SONOVA

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENTS

14.19 STIMWAVE LLC

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENT

14.2 ZHEJIANG NUROTRON BIOTECHNOLOGY CO., LTD

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

15 QUESTIONNAIRE

16 RELATED REPORTS

표 목록

TABLE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 2 NORTH AMERICA CARDIAC RESYNCHRONIZATION THERAPY DEVICES (CRT-D) IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 3 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA EYE IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA NEUROSTIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA ACTIVE IMPLANTABLE HEARING DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA VENTRICULAR ASSIST DEVICES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA IMPLANTABLE HEART MONITORS/ INSERTABLE LOOP RECORDERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA BRACHYTHERAPY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA IMPLANTABLE GLUCOSE MONITORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA DROPPED FOOT IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA SHOULDER IMPLANTS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA IMPLANTABLE INFUSION PUMPS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA TRADITIONAL SURGICAL METHODS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA CARDIOVASCULAR IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA NEUROLOGICAL IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA HEARING IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA OTHERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA HOSPITALS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA SPECIALIZED CLINICS IN BREAST RECONSTRUCTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA CLINICS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 44 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 45 U.S. IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 46 U.S. TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 47 U.S. IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 48 U.S. NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 49 U.S. IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 50 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 51 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 52 U.S. ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 54 CANADA IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 55 CANADA TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 56 CANADA IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 57 CANADA NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 58 CANADA IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 59 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 60 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 61 CANADA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 62 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 63 MEXICO IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 64 MEXICO TRANS VENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 65 MEXICO IMPLANTABLE CARDIAC PACEMAKERS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 66 MEXICO NEURO STIMULATORS IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 67 MEXICO IMPLANTABLE ACCESSORIES IN ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 68 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY SURGERY TYPE, 2019-2028 (USD MILLION)

TABLE 69 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY PROCEDURE, 2019-2028 (USD MILLION)

TABLE 70 MEXICO ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)

그림 목록

FIGURE 1 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION

FIGURE 2 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 SURGERY TYPE LIFELINE CURVE

FIGURE 7 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 10 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SEGMENTATION

FIGURE 12 THE INCREASE IN DEMAND FOR ACTIVE MEDICAL IMPLANTABLE DEVICES EXPECTED TO DRIVE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 CARDIOVASCULAR SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET IN 2021 & 2028

FIGURE 14 NORTH AMERICA IS EXPECTED TO DOMINATE THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET

FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)

FIGURE 17 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2020

FIGURE 18 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, 2019-2028 (USD MILLION)

FIGURE 19 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, CAGR (2021-2028)

FIGURE 20 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT, LIFELINE CURVE

FIGURE 21 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2020

FIGURE 22 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, 2019-2028 (USD MILLION)

FIGURE 23 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, CAGR (2021-2028)

FIGURE 24 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY SURGERY TYPE, LIFELINE CURVE

FIGURE 25 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2020

FIGURE 26 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, 2019-2028 (USD MILLION)

FIGURE 27 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, CAGR (2021-2028)

FIGURE 28 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PROCEDURE, LIFELINE CURVE

FIGURE 29 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2020

FIGURE 30 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 31 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, CAGR (2021-2028)

FIGURE 32 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: SNAPSHOT (2020)

FIGURE 34 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020)

FIGURE 35 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2021 & 2028)

FIGURE 36 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY COUNTRY (2020 & 2028)

FIGURE 37 NORTH AMERICA ACTIVE MEDICAL IMPLANTABLE DEVICES MARKET: BY PRODUCT (2021-2028)

FIGURE 38 NORTH AMERICA ACTIVE IMPLANTABLE MEDICAL DEVICES MARKET: COMPANY SHARE 2020 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

The North America Active Medical Implantable Devices Market size will be worth USD 12,665.68 million by 2028.
The North America Active Medical Implantable Devices Market growth rate will be 7.9% by 2028.
The Increasing R&D activities in the healthcare industry and increase in healthcare expenditure are the growth drivers of the North America Active Medical Implantable Devices Market.
The product, surgery type, procedure, and end users are the factors on which the North America Active Medical Implantable Devices Market research is based.
The major companies in the North America Active Medical Implantable Devices Market are NeuroPace, Inc., Axonics, Inc., Stimwave LLC, NEVRO CORP, Second Sight, BIOTRONIK, ABIOMED, Boston Scientific Corporation, Medtronic, Abbott, Eckert & Ziegler., Sonova, Zhejiang Nurotron Biotechnology Co., Ltd, Demant A/S, Cochlear Ltd, Microson, Oticon Medical, Nano Retina, GluSense, MED-EL Medical Electronics.